Rizvi Syed Ali-aamir insider trades
Rizvi Syed Ali-aamir has filed 7 Form 4s with the SEC that we hold, for Caribou Biosciences, Inc. (CRBU) (Chief Medical Officer), PSTX (Chief Medical Officer) and Rocket Pharmaceuticals, INC. (RCKT) (Chief Medical Officer). Across all of them we count 0 purchases worth $0 and 1 sale worth $35.5K reported on Form 4. None of these purchases or sales is dated in the last 12 months. The largest single trade was a sale of 5,627 shares of Caribou Biosciences, Inc. worth $35.5K, dated 2023-01-19. The first filing on our record is dated 2022-01-25 and the latest 2026-02-13.
Caribou Biosciences, Inc. (CRBU)
| Trade date | Code | Shares | Value as filed | Filed |
|---|---|---|---|---|
| 2023-01-19 | S, sale reported on Form 4 | 5,627 | $35.5K | 2023-01-20 |
PSTX
No purchase or sale of common stock reported here; these filings cover grants, option exercises or other codes.
Rocket Pharmaceuticals, INC. (RCKT)
No purchase or sale of common stock reported here; these filings cover grants, option exercises or other codes.
Counted from the Form 4 filings this reporting owner (SEC CIK 1897621) filed on EDGAR. Values are the transaction values as filed. See every filing on EDGAR, or browse insider buying and today's insider purchases.
Source: U.S. Securities and Exchange Commission (EDGAR) and other official
government data · Updated 2026-10-12 ·
For informational purposes only, not investment advice.
Privacy · Terms